Structural Organization and Promoter Activity of the Human Ryudocan Gene

スポンサーリンク

概要

• 論文の詳細を見る
• 1996-05-01

著者

• TAKAGI Akira

  Department of Medical Technology, Nagoya University School of Health Sciences

• Saito H

  Department Of Hematology Meitetsu Hospital

• Hiraoka Sakamaki

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• Takagi A

  Department Of Medical Technology Nagoya University School Of Health Sciences

• Katsumi A

  Department Of Hematology-oncology Nagoya University Graduate School Of Medicine

• Katsumi Akira

  名古屋市立大学 医学系研究科血液腫瘍内科学

• Hamaguchi M

  Nagoya National Hospital Nagoya

• Hamaguchi Motohiro

  Department Of Hematology Clinical And Research Center National Hospital Organization Nagoya Medical

• TAKAGI Akira

  First Department of Internal Medicine, Nagoya University School of Medicine

• KOJIMA Tetsuhito

  First Department of Internal Medicine, Nagoya University School of Medicine

• TSUZUKI Shinobu

  First Department of Internal Medicine, Nagoya University School of Medicine

• KATSUMI Akira

  First Department of Internal Medicine, Nagoya University School of Medicine

• YAMAZAKI Tomio

  First Department of Internal Medicine, Nagoya University School of Medicine

• SUGIURA Isamu

  First Department of Internal Medicine, Nagoya University School of Medicine

• HAMAGUCHI Motohiro

  First Department of Internal Medicine, Nagoya University School of Medicine

• SAITO Hidehiko

  First Department of Internal Medicine, Nagoya University School of Medicine

• Yamazaki Tomio

  Department Of Hemostasis And Thrombosis Clinical Research Center Nagoya Medical Center

• Yamazaki Tomio

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Sugiura Isamu

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Tsuzuki Shinobu

  名古屋大学 第1内科

• Tsuzuki Shinobu

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Saito H

  Nagoya Central Hospital

• Katsumi Akira

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Saito Hidehiko

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Yamazaki T

  Department Of Hemostasis And Thrombosis Clinical Research Center Nagoya Medical Center

• Saito H

  Nagoya National Hospital

• Kojima Tetsuhito

  First Department First Department Of Internal Medicine Nagoya University School Of Medicine:departme

• Yamazaki Takashi

  Department Of Life Science Graduate School Of Bioscience And Biotechnology Tokyo Institute Of Techno

• Saito Hidehiko

  Nagoya Central Hospital Nagoya Jpn

• Shishido Hideo

  Third Department Of Internal Medicine Dokkyo University School Of Medicine

関連論文

• A SIMPLE AND SELECTIVE HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF PARAQUAT AND DIQUAT IN HUMAN URINE
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
• Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
• Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
• Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
• Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils : involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines
• Smoking, drinking, sleeping habits, and other lifestyle factors and the risk of systemic lupus erythematosus in Japanese females : findings from the KYSS study
• Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
• Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
• Allogeneic Peripheral Blood Stem Cell Transplantation in 23 Adult Patients With Hematologic Malignancies: A Single-Center Experience
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
• Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
• Mutational analysis of SOS1 gene in acute myeloid leukemia
• Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
• Mutated RAS Induced PLD1 Gene Expression through Increased Sp1 Trascription Factor
• Molecular Defects Associated with Antithrombin Deficiency and Dilated Cardiomyopathy in a Japanese Patient
• Recurrent Mutations of Factor XI Gene in Japanese
• Structural Organization and Promoter Activity of the Human Ryudocan Gene
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
• Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
• High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
• Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors
• Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
• High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
• Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
• Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
• Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
• Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
• Molecular Cloning, Genomic Organization, Promoter Activity, and Tissue-Specific Expression of the Mouse Ryudocan Gene^1
• Analysis for heterozygosity of protein S mRNA: application to genetic screening and family studies in hereditary protein S deficiency
• Effect of Co-administration of Cationic Macromolecules on the In Vivo Disposition and situ Renal Disposition Characteristics of rhIL-11
• Interferon-α treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation
• Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission
• Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
• A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
• Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
• Quality of Life in Adult Patients After Stem Cell Transplantation
• Superior Efficacy of MMCP Regimen Compared with VMCP and MMPP Regimens in the Treatment of Multiple Myeloma
• Posttreatment Nadir M-Protein Level Is a Stronger Discriminator of Survival Following Plateau Attainment Than Is Percent Reduction in M-Protein in Patients With IgG Myeloma
• Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow transplantation
• Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease
• Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
• Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
• Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
• Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
• Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
• Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond
• Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions
• Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor
• Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
• Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin
• Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
• Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
• Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
• Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
• Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas
• Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
• WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
• WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
• Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
• The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
• Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
• Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma
• Historical changes on the fisheries management in Cambodia
• No Significant Association Between HA-1 Incompatibility and Incidence of Acute Graft-Versus-Host Disease After HLA-Identical Sibling Bone Marrow Transplantation in Japanese Patients
• Retrospective Study on the Impact of Hepatitis B and Hepatitis C virus Infection on Hematopoietic Stem Cell Transplantation in Japan
• Novel Synthesized Trimannose Conjugate Induces Endocytosis and Expression of Immunostimulatory Molecules in Monocytic Leukemia Cells
• Genetic Abnormalities of Bernard-Soulier Syndrome
• Retrospective study of inhibitor formation in Japanese hemophiliacs
• Unrelated bone marrow transplantation from the National Marrow Donor Program
• WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
• Filling of Sub-μm Through-holes by Self-sputter Deposition
• Copper Self-Sputtering by Planar Magnetron
• Overexpression of the Wilms′tumor gene WT1 in head and neck squamous cell carcinoma
• Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
• Efficient Induction of Pptide - Specific Cytotoxic T Lymphocytes by LPS - Activated Spleen Cells
• Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma : case reports of Japanese patients
• Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
• A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
• Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
• Unrelated Bone Marrow Transplantation Induced Long-Term Remission in a Patient with Life-Threatening Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Mutation of ARHGAP9 in patients with coronary spastic angina
• Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation

もっと見る 閉じる

スポンサーリンク